Remove tag commercial-strategy
article thumbnail

Orphan drugs and where to launch them: The keys to Europe’s forgotten territories

Pharmaceutical Technology

The commercial investment required to research and develop an innovative drug, prove its safety and efficacy, and bring it to market is staggering. Go-to-market strategies. Each country in Europe carries unique complexities, which makes it difficult for companies to deploy turnkey commercial strategies on a pan-European level.

Drugs 147
article thumbnail

Grand Rounds October 20, 2023: A National Initiative to Eliminate Hepatitis C in the United States – Why This Matters to Clinical Trialists (Rachael L. Fleurence, PhD, MSc; Joshua M. Sharfstein, MD)

Rethinking Clinical Trials

point of care diagnostic tests, provide broad access to curative Hepatitis C medications with a national subscription model, with Medicare co-pay assistance and commercial insurance coverage. Our review of the data from other countries is that having same-day tests available for certain settings and populations is a helpful strategy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Preview of Pharma Commercials at Super Bowl 2024: From Touching Down with TUMS to Tackling Menopause

XTalks

Pharma commercials at Super Bowl 2024 will include ones for newly approved menopause drug Veozah and a unique partnership between antacid giant TUMS and sports betting company Draft Kings. At $7 million for 30 seconds of airtime, the Super Bowl is the most expensive time and place of the year for TV commercials.

article thumbnail

AI-Powered Precision Engagement in Commercial and Medical Functions

Intouch Solutions

Commercial : Improved experience and communication between patients and doctors. However, in keeping with the nature of this short article, I will highlight a couple of the most relevant activities: Data Aggregation Strategy and Analysis AI-powered systems gather data from diverse sources. How is AI being used in precision engagement?

article thumbnail

What challenges does the advanced therapies sector face? 

Drug Discovery World

Lentivirus strategies are one of the most widely used tools in biomedical research and clinical testing, says Stella Vnook, CEO, Likarda. “Dr  Even as more therapies become commercially available, costs remain high and insurer knowledge needs to keep pace. Fostering open innovation and collaboration could help address this issue.

article thumbnail

Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of Adjuvanted COVID-19 Vaccine Candidate

The Pharma Data

All parties remain confident that their respective strategies and collaborations for COVID-19 vaccine development will be able to maximize their respective and overall impacts against the COVID-19 pandemic. About Trimer-Tag© Technology. . EMERYVILLE, Calif. and CHENGDU, China , Feb. About S-Trimer COVID-19 Vaccine Candidate.

article thumbnail

Clover biopharmaceuticals raises $230 M; BrainStorm after ALS; BARDA grants $5.65 M LightDeck for SARS-CoV-2 antigen test; Libtayo for first-line advanced NSCLC subset

Delveinsight

The company plans to use the capital to expand its pipeline of protein-based vaccines and biologic cancer therapies utilizing its innovative and proprietary Trimer-Tag technology platform. Besides, Clover is set to advance multiple new pipeline products in 2021 and expand its in-house R&D and cGMP commercial biomanufacturing capabilities.